TE_6822
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 179.66 |
| Counts of samples | TCGA_tumor:796; TCGA_normal:3; GTEx:1 |
| TSS | chr3(+):18963446 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_6822.1 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,18988206,18988226 |
| teRNA_6822.2 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19043270,19043290 |
| teRNA_6822.3 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19021376,19021503,19043270,19043290 |
| teRNA_6822.4 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19004638,19004658 |
| teRNA_6822.5 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19075965,19076080,19078883,19078934,19126386,19126466,19127013,19127033 |
| teRNA_6822.6 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19021376,19021396 |
| teRNA_6822.7 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19021376,19021503,19024289,19024309 |
| teRNA_6822.8 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19075965,19076080,19078880,19078934,19126386,19126466,19127013,19127033 |
| teRNA_6822.9 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19075965,19076080,19078880,19078900 |
| teRNA_6822.10 | - | Intergenic | Non-coding | Non-coding | chr3(+):18963447,18963573,18966293,18966407,19075965,19076080,19078883,19078934,19125733,19125805,19126386,19126466,19127013,19127033 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
